Menu
  • Join
  • Login
  • Contact
 

Search abstracts


A performance improvement project to increase appropriate reporting of weekly paclitaxel infusion related hypersensitivity adverse drug reactions at a major tertiary cancer center.

  • In: Hospital Pharmacy - Posters
  • At: Basel (Switzerland) (2008)
  • Type: Poster
  • Poster code: HPS-P-005
  • By: LAL, Lincy (University of Texas - MD Anderson Cancer Center, Houston, United States of America)
  • Co-author(s): Dana, William (University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America)
    Gerber, Donna (University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America)
  • Abstract:

    Objectives: This prospective performance improvement project identifies, intervenes, and measures the impact of a clinical safety and effectiveness program to increase and improve the rate of appropriate reporting of weekly paclitaxel infusion related hypersensitivity reactions in an electronic medical record (EMR) system at a major tertiary..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses